Stay updated on Anifrolumab SubQ in Lupus Adults Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.

Latest updates to the Anifrolumab SubQ in Lupus Adults Clinical Trial page
- Check3 days agoChange DetectedUpdated from Revision: v3.0.1 to v3.0.2 and removed the 'Back to Top' link; no substantive changes to core content or pricing.SummaryDifference0.6%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.6%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as numerous updates to study statuses and contact information. However, several location-related terms and details have been removed.SummaryDifference39%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has updated its version from v2.16.11 to v2.16.12 and changed the date from 2025-07-11 to 2025-08-12.SummaryDifference1.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Anifrolumab SubQ in Lupus Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.